FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308379764> ?p ?o ?g. }

• W4308379764 abstract "<h3>Background</h3> Natural killer (NK) cells are innate cytotoxic and immunoregulatory lymphocytes that play a critical role in tumor immunosurveillance. Their activation states are regulated by an interplay of activating and inhibitory surface receptors, including T-cell immunoglobulin and mucin-domain containing molecule 3 (TIM-3), an immune checkpoint receptor (ICR) that is expressed on terminally-differentiated NK cells. The role TIM-3 plays in the context of NK cell-mediated anti-tumor response remains evasive, partly because TIM-3 has four known ligands: galectin-9, phosphatidylserine, HMGB1 and CEACAM-1. <h3>Methods</h3> In the context of head and neck squamous cell carcinoma (HNSCC), single-cell RNA sequencing and flow cytometry were implemented to study the prevalence, phenotypes and functional differences of TIM-3+ NK cells in patient tumors and blood. <i>In vitro</i> killing and proliferation assays were used to evaluate whether the four TIM-3 ligands differentially modulate TIM-3+ NK cell functions and whether abrogation of TIM-3/ligand interaction is a valid therapeutic strategy to enhance NK cell-mediated anti-tumor effector mechanisms. Finally, TCGA survival analysis and digital spatial profiling were employed to study the potential impact of etiology-associated differences on HNSCC patient survival. <h3>Results</h3> We demonstrate that TIM-3 is the dominant NK cell ICR, that it marks dysfunctional NK cells in tumors but not in circulation, and that galectin-9 is the only TIM-3 ligand that consistently suppresses NK cell cytotoxic and proliferative capacity. Galectin-9-induced effects on cytotoxicity can be abrogated using the clinical-grade anti-TIM-3 blocking antibody, MBG453. Clinically, high intratumoral TIM-3+ NK cell gene signature associates with worse outcome in HPV+, but not HPV- HNSCC patients. This may be due to higher intratumoral galectin-9 protein expression in HPV+ HNSCC lesions, as well as higher frequencies of circulating and tumor-infiltrating TIM-3+ NK cells in HPV+ patients. <h3>Conclusions</h3> Our data stress the importance of TIM-3 in the context of NK cells and suggest that targeting the TIM-3/galectin-9 pathway may be a cogent immunotherapeutic strategy to reinvigorate NK cell effector function in HPV+ HNSCC patients. <h3>Acknowledgements</h3> We thank Merida Serrano, Amy Cuda and Denise Kroll for assistance with patient sample procurement. This research utilized the Hillman Cancer Center Flow Cytometry Core Facility, supported in part by award P30 CA047904 (RLF). This research was supported in part by the University of Pittsburgh Center for Research Computing through the resources provided. Specifically, this work used the HTC cluster, which is supported by NIH award number S10OD028483. <h3>Ethics Approval</h3> Peripheral blood and tumor tissues from treatment-naïve HNSCC patients were collected with their written consent in accordance with the Declaration of Helsinki, under the University of Pittsburgh Cancer Institute Review Board–approved protocol (99-069)." @default.
• W4308379764 created "2022-11-11" @default.
• W4308379764 creator A5006651636 @default.
• W4308379764 creator A5012037714 @default.
• W4308379764 creator A5015485877 @default.
• W4308379764 creator A5021772081 @default.
• W4308379764 creator A5026264123 @default.
• W4308379764 creator A5044898944 @default.
• W4308379764 creator A5045824501 @default.
• W4308379764 creator A5065997584 @default.
• W4308379764 creator A5075238702 @default.
• W4308379764 creator A5082815400 @default.
• W4308379764 creator A5086074491 @default.
• W4308379764 creator A5091645375 @default.
• W4308379764 date "2022-11-01" @default.
• W4308379764 modified "2023-10-02" @default.
• W4308379764 title "490 Galectin-9 drives TIM-3+ natural killer cell dysfunction in head and neck squamous cell carcinoma" @default.
• W4308379764 doi "https://doi.org/10.1136/jitc-2022-sitc2022.0490" @default.
• W4308379764 hasPublicationYear "2022" @default.
• W4308379764 type Work @default.
• W4308379764 citedByCount "0" @default.
• W4308379764 crossrefType "proceedings-article" @default.
• W4308379764 hasAuthorship W4308379764A5006651636 @default.
• W4308379764 hasAuthorship W4308379764A5012037714 @default.
• W4308379764 hasAuthorship W4308379764A5015485877 @default.
• W4308379764 hasAuthorship W4308379764A5021772081 @default.
• W4308379764 hasAuthorship W4308379764A5026264123 @default.
• W4308379764 hasAuthorship W4308379764A5044898944 @default.
• W4308379764 hasAuthorship W4308379764A5045824501 @default.
• W4308379764 hasAuthorship W4308379764A5065997584 @default.
• W4308379764 hasAuthorship W4308379764A5075238702 @default.
• W4308379764 hasAuthorship W4308379764A5082815400 @default.
• W4308379764 hasAuthorship W4308379764A5086074491 @default.
• W4308379764 hasAuthorship W4308379764A5091645375 @default.
• W4308379764 hasBestOaLocation W43083797641 @default.
• W4308379764 hasConcept C121608353 @default.
• W4308379764 hasConcept C129374314 @default.
• W4308379764 hasConcept C1491633281 @default.
• W4308379764 hasConcept C154317977 @default.
• W4308379764 hasConcept C167672396 @default.
• W4308379764 hasConcept C202751555 @default.
• W4308379764 hasConcept C203014093 @default.
• W4308379764 hasConcept C206191192 @default.
• W4308379764 hasConcept C2776530083 @default.
• W4308379764 hasConcept C2776833033 @default.
• W4308379764 hasConcept C2778102761 @default.
• W4308379764 hasConcept C28651165 @default.
• W4308379764 hasConcept C502942594 @default.
• W4308379764 hasConcept C54355233 @default.
• W4308379764 hasConcept C55493867 @default.
• W4308379764 hasConcept C86803240 @default.
• W4308379764 hasConcept C8891405 @default.
• W4308379764 hasConceptScore W4308379764C121608353 @default.
• W4308379764 hasConceptScore W4308379764C129374314 @default.
• W4308379764 hasConceptScore W4308379764C1491633281 @default.
• W4308379764 hasConceptScore W4308379764C154317977 @default.
• W4308379764 hasConceptScore W4308379764C167672396 @default.
• W4308379764 hasConceptScore W4308379764C202751555 @default.
• W4308379764 hasConceptScore W4308379764C203014093 @default.
• W4308379764 hasConceptScore W4308379764C206191192 @default.
• W4308379764 hasConceptScore W4308379764C2776530083 @default.
• W4308379764 hasConceptScore W4308379764C2776833033 @default.
• W4308379764 hasConceptScore W4308379764C2778102761 @default.
• W4308379764 hasConceptScore W4308379764C28651165 @default.
• W4308379764 hasConceptScore W4308379764C502942594 @default.
• W4308379764 hasConceptScore W4308379764C54355233 @default.
• W4308379764 hasConceptScore W4308379764C55493867 @default.
• W4308379764 hasConceptScore W4308379764C86803240 @default.
• W4308379764 hasConceptScore W4308379764C8891405 @default.
• W4308379764 hasLocation W43083797641 @default.
• W4308379764 hasOpenAccess W4308379764 @default.
• W4308379764 hasPrimaryLocation W43083797641 @default.
• W4308379764 hasRelatedWork W132117956 @default.
• W4308379764 hasRelatedWork W1483170373 @default.
• W4308379764 hasRelatedWork W1988607546 @default.
• W4308379764 hasRelatedWork W199336330 @default.
• W4308379764 hasRelatedWork W2044569404 @default.
• W4308379764 hasRelatedWork W2065973567 @default.
• W4308379764 hasRelatedWork W2093122832 @default.
• W4308379764 hasRelatedWork W2154561989 @default.
• W4308379764 hasRelatedWork W2475299811 @default.
• W4308379764 hasRelatedWork W394065362 @default.
• W4308379764 isParatext "false" @default.
• W4308379764 isRetracted "false" @default.
• W4308379764 workType "article" @default.